Jane D. Holland
- Oncology top 5%
- Cancer Cells and Metastasis 5
- Chemokine receptors and signaling 3
- Cytokine Signaling Pathways and Interactions 2
- Cancer Research top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 4
- Wnt/β-catenin signaling in development and cancer 3
- Cancer-related gene regulation 3
- Fibroblast Growth Factor Research 1
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Walter BirchmeierAlexandra Klaus‐BergmannAlistair N. GarrattUlrike ZieboldPeter WendAnnika Wulf-GoldenbergShaun R. McCollChareeporn Akekawatchai
- Journals
- Journal of Biological Chemistry (1 paper)The EMBO Journal (2 papers)Cancer Research (2 papers)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Jane D. Holland
11 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Oncology 569
- Cancer Research 244
- Molecular Biology 879
- Immunology 160
- Cell Biology 100
Countries citing papers authored by Jane D. Holland
This map shows the geographic impact of Jane D. Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane D. Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane D. Holland more than expected).
Fields of papers citing papers by Jane D. Holland
This network shows the impact of papers produced by Jane D. Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane D. Holland. The network helps show where Jane D. Holland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jane D. Holland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 140 | |
| 2 | 2017 | 9 | |
| 3 | 2015 | 141 | |
| 4 | 2015 | 29 | |
| 5 | 2015 | 60 | |
| 6 | 2013 | 84 | |
| 7 | 2013 | 62 | |
| 8 | 2013 | 390 | |
| 9 | 2010 | 189 | |
| 10 | 2006 | 84 | |
| 11 | 2005 | 87 |
About Jane D. Holland
Jane D. Holland is a scholar working on Oncology, Immunology and Allergy and Immunology, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Epigenetics and DNA Methylation (4 papers), Immunotherapy and Immune Responses (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cancer-related gene regulation (3 papers), Chemokine receptors and signaling (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Oncology (569 citations), Cancer Research (244 citations) and Molecular Biology (879 citations). Jane D. Holland has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Walter Birchmeier, Alexandra Klaus‐Bergmann, Alistair N. Garratt, Ulrike Ziebold, Peter Wend, Annika Wulf-Goldenberg, Shaun R. McColl, Chareeporn Akekawatchai, Marina Kochetkova and Regina Vogel. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.